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Abstract
Background: The incidence of achalasia in sub-
Saharan Africa is not known. Experience in our region 
suggests the disorder affects mainly younger patients. 
Esophagomyotomy is the gold standard treatment for 
achalasia. Benefits of laparoscopic treatment are well 
documented in western populations. African data is 
insufficient. Methods: A retrospective review of patients 
over 16 years who underwent esophagomyotomy at 
Tenwek Hospital (2008–2017). The primary outcome 
was improvement in symptoms before and after surgery 
as measured using the Eckardt score— lower scores 
for dysphagia, regurgitation, pain, weight loss indicate 
less severe symptoms. The secondary outcomes were 
duration of surgery, length of myotomy, length of 
hospital stay, and complication rate. Data analysis used 
ANOVA. Results: 54 patients were included: 28 with 
laparoscopic Heller myotomy (LHM), 26 with open 
Heller myotomy (OHM). LHM patients were younger 
than OHM patients (p<0.05). Patients who had LHM 
had lower postoperative Eckardt scores (p<0.05). 
Duration of surgery for LHM was longer (p<0.001) 
than for OHM, conversion rate was 10.71%, and length 
of the myotomy was unaltered. No difference was seen 
in hospital stay or complication rate between the two 
groups. Conclusion: LHM is effective and safe in a rural 
East African setting, with excellent functional outcomes 
compared with open techniques. Thus, laparoscopy can 
be feasible worldwide.
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Introduction
Esophagomyotomy (Heller myotomy) is described as 
the gold standard treatment for esophageal achalasia 
(1,2). Achalasia is a neurodegenerative motility disorder 
of the esophagus, resulting in deranged peristalsis and 
loss of lower esophageal sphincter function. The etiology 
is unclear but likely to be multifactorial (3). Treatment 
of achalasia involves myotomy and has been commonly 
managed with laparoscopic Heller myotomy (LHM).
Achalasia is a rare primary esophageal motility disorder 
that occurs with equal distribution, irrespective of 
gender and race. The incidence of achalasia in western 
populations is as low as 0.5–1/100,000 people and 
accounts for 3–20% of cases among esophageal diseases 
(4). The incidence of achalasia in sub-Saharan Africa has 
not been established; a few studies exist, mainly within 
the northern and western Africa regions (5,6), but 
studies are lacking in East and Central Africa. Therefore, 
we sought to evaluate the efficacy and safety of LHM in 
our population. We undertook this 9-year retrospective 
review to compare LHM with open Heller myotomy 
(OHM).
Materials and Methods
Patients, setting, and surgical technique
The study was conducted at Tenwek Hospital, a rural 
hospital in western Kenya in the south rift region. 
The research and ethics review committee at Tenwek 
Hospital gave approval to proceed with the study, after 
which all patients who were included in the study were 
informed and gave written consent for use of any data 
and photos. 
We reviewed retrospectively records of all patients who 
had a diagnosis of achalasia and who underwent LHM or 
originaL articLe
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OHM between 2008 and 2017. The age of 
these patients in the series was 16–74 years. 
For each patient included, the diagnosis 
had been established by barium swallow 
esophagram; an endoscopic evaluation 
excluded other pathology. Exclusion 
criteria included: 1) age <16 – the focus was 
on adult patients, and in the data collected 
no paediatric patient files were found with a diagnosis 
of achalasia, 2) patients who underwent endoscopic 
dilation as therapy for achalasia before myotomy.
For the procedure, the patient is under general 
anaesthesia in low lithotomy position with the surgeon 
positioned caudal and the assistants on the right and 
left of the patient. The patient’s abdomen is insufflated 
with carbon dioxide, and laparoscopic instruments are 
introduced via five keyhole incisions (1–2 cm) made on 
the abdomen. The lower oesophagus was approached 
and a lengthwise cut was made in the muscle layer. Care 
was taken to cut only the muscle layer, leaving the inner 
lining of the oesophagus intact. As this procedure is often 
complicated by acid reflux after the operation, a partial or 
complete fundoplication is also performed at the same 
time to minimize this. The Dor partial fundoplication 
was the anti-reflux procedure performed for all patients. 
Participating surgeons prefer this method to avoid the 
distal esophagus angulating, and because it requires less 
extensive dissection than total fundoplication (7,8). 
Most participating surgeons routinely use intraoperative 
esophagogastroduodenoscopy (EGD) during LHM, 
after completion of the myotomy.
Outcome measures
The primary outcome was improvement in pre- to 
postoperative symptoms, measured by Eckardt 
Symptom Score (ESS). The ESS is the grading system 
most frequently used to evaluate symptoms and stages 
of achalasia and efficacy of treatment. It attributes points 
from 0 to 4, based on the symptoms of the disease 
(dysphagia, regurgitation, chest pain, and weight loss), 
giving a cumulative score that ranges from 0 to 12 (Table 
1). Scores of 0–1 correspond to clinical stage 0, 2–3 to 
stage I, 4–6 to stage II, and a score >6 to stage III (Table 
2) (9,10). Secondary outcomes included duration of 
surgery, length of myotomy, hospital length of stay, and 
complication rate. Possible complications included 
mucosal perforations, inadvertent pleural cavity breech, 
unplanned take back. Data on intraoperative revision of 
the myotomy post-EGD were not available for analysis.
Data collection
Patient charts from 2008–2014 were reviewed vide 
paper medical records while those from 2014–2017 
were accessed vide the hospital electronic medical 
record system. Files of patients who underwent 
esophagomyotomy for a diagnosis of achalasia between 
2008 and 2017 were retrieved and reviewed. Patients 
who were 16 years and below were excluded as were 
patients who had undergone endoscopic dilation as 
therapy for achalasia before myotomy. Patients had 
been evaluated in the surgical outpatient clinic; they 
completed a questionnaire based on the ESS to evaluate 
the current symptoms they were experiencing. In our 
setup, data were collected with the help of clinical 
translators who had the questionnaire explained to them 
beforehand, and data were entered in real time at the 
time of the interviews. The surgeon selected the patients; 
selection criteria was based on the availability and safe 
functionality of the laparoscopy equipment. Patients 
who did not undergo the procedure were scheduled for 
open Heller esophagomyotomy. 
Preoperative measurements consisted of identifying 
common symptoms associated with the disorder 
and then quantifying them as scores. Scoring used a 
self-designed questionnaire. Symptoms were scored 
according to their frequency of dysphagia, regurgitation 
and retrosternal pain, and quantity of weight lost based 
on a score of 0 to 3, to give a possible cumulative total of 
between 0 and 12 (Tables 1 and 2). The result was the 
Eckardt score. As an example, a patient with occasional 
dysphagia, daily regurgitation, occasional retrosternal 
pain and with 6 kg weight loss would have an Eckardt 
score of 6.
Postoperative symptomatology was assessed using 
the same parameters to calculate posttreatment 
Eckardt score and correlate this score with the clinical. 
Standardized questionnaires were filled in during clinic 
Table 1. The Eckardt score: final score is the sum of the 4 components
Score Dysphagia Regurgitation
Retrosternal 
pain
Weight loss 
(kg)
0 None None None None
1 Occasional Occasional Occasional <5
2 Daily Daily Daily 5–10
3 Each meal Each meal Each meal >10
Table 2. Clinical scoring system for achalasia (16)
Stage Eckardt score Clinical implication posttreatment
0 0–1 Remission
I 2–3 Remission
II 4–6 Treatment failure
III >6 Treatment failure
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visits or through a telephone interview with 
the patients. Questionnaires were filled 
between 6 and 24 months postoperative. The 
questionnaires also contained information 
about preoperative investigations, i.e. CXR, 
barium swallows and CT scans.
Statistical analysis
Groups were compared using chi-square 
for categorical data, and Student t-test and 
Mann-Whitney test for continuous data. 
ANOVA was used to analyse the interaction 
between use of intraoperative EGD and 
postoperative ESS.
Results
Fifty-four patients met the inclusion 
criteria: 28 had undergone LHM and 26 
OHM. Table 1 shows descriptive statistics 
comparing the two groups. Patients who had 
LHM were younger than those with OHM 
(p<0.05), with no significant difference in 
pre-op ESS or duration of symptoms.
The t mean preoperative ESS for the total patient 
population was 7.14, indicating symptoms as being 
clinical stage III (Table 2) (16). Of the four score 
components, the most common presenting complaint 
was dysphagia seen in 37.1%, next was weight loss at 
25%, pain was experienced by 21.4% and regurgitation 
by 17.9%. The presence of regurgitation seemed to be a 
late sign, indicating advanced disease, whereas dysphagia 
was the earliest symptom, causing the greatest effect on 
patient quality of life.
Primary outcome
Among all patients, 54(93%) experienced lower 
postoperative ESS, and thus improvement in symptoms. 
Patients who had had LHM had lower postoperative 
ESS (p<0.05, Table 3) than those who had an OHM.
With no difference between groups in preoperative 
ESS, the indication is a possible greater symptomatic 
improvement among those undergoing LHM.
The use of intraoperative EGD was disproportionately 
represented among the LHM group (OR 36.82, 95% CI, 
4.32–313.63 for LHM), due to its inclusion as a standard 
part of this operative technique. When controlling 
for intraoperative EGD, postoperative ESS no longer 
demonstrates significant differences between groups 
(p=0.4).
Secondary outcomes
Duration of surgery for LHM was longer than for 
OHM (p<0.001) with a 10.71% conversion rate, but 
length of myotomy did not differ. No statistically 
significant difference was observed in hospital length 
of stay, with LHM being slightly shorter than OHM, 
or in complication rate, which was 7.14% overall. No 
mortalities or re-admissions were reported. Table 
4 shows these results. Complications included two 
mucosal perforations, an inadvertent pleural cavity 
breech, and an unplanned take back. Blood loss for the 
procedure was approximately 10 cc.
Discussion
In treating achalasia, the focus is on alleviating 
symptoms rather than on addressing the etiology—a 
neurodegenerative pathology that is irreversible. The 
most common primary symptom on presentation 
remains dysphagia, next are pain and regurgitation (9). 
The frequency of symptoms in our patient population 
was consistent with that in north and west Africa where 
similar studies have been conducted (5,6). Compared 
with data in industrialized countries, the frequency of 
symptoms was also comparable (2,3,11,15). The ESS 
is a fair measure of achalasia symptom severity; its 
strengths are in assessing dysphagia and regurgitation, 
factors that consistently performed well when assessed 
for reliability and validity. The apparent weaknesses of 
the ESS lie in the chest pain, due to the heterogeneous 
nature of chest pain, and weight loss, because weight loss 
may be multifactorial in origin (9).
Our study shows that Heller myotomy affords significant 
relief of the symptoms of dysphagia, regurgitation 
and chest pain. Total symptom scores improved for 
Table 3. Descriptive statistics, compared between groups
Laparoscopic 
n=28 Open n=26 p value
Age (years) mean ± SD 30.6±13.5 42.2 ± 15.0 <0.05
Gender, n (%) female 15 (53.6%) 13 (50%) 0.79
Duration of symptoms, 
mean ± SD 20.7±19.2 18.9±16.8 0.72
Pre-op Eckardt score, 
median ± IQR 7.5±4 8.0±2 0.3
Table 4. Primary and secondary outcome measures, compared between 
groups
Outcome measures
Laparoscopic 
n=28 Open n=26 p value
Post-op Eckardt score, 
median ± IQR 2.0±0 3.0±1 <0.05
Duration of surgery (min), 
median ± IQR 177.5±51.3 112.5±76.3 <0.001
Length of myotomy (cm), 
mean ± SD 7.39±1.4 7.6±1.1 0.56
Length of hospital stay 
(days), mean ± SD 3.75±1.4 4.39±1.3 0.1
Complication rate, n (%) 4 (14.3%) 4 (15.4%) 0.6
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all patients, a success rate that agrees with published 
literature (7). With the significant improvement on 
patient symptoms after LHM, we can infer a better 
quality of life, as described by Decker et al. (11).
This single-centre retrospective review provides a 
unique analysis of surgical treatment of achalasia in 
a rural African setting with resource limitation. The 
patient population of this study is also different from that 
presented in western data, with a higher likelihood of 
advanced pathology such as sigmoid esophagus than in 
the western population and coupled with limitations in 
diagnostic capabilities (lack of manometry) introduces 
the potential for poor outcomes. 
The challenges of carrying out laparoscopy in a rural 
setting extend beyond just having the right equipment. 
Issues encountered in our setting include unreliable 
electricity, lack of operative support personnel to assist 
in troubleshooting problems that occur intraoperatively, 
supply chain issues, and patients who have limited 
resources to fund the procedure and to allow appropriate 
follow-up. While some of these factors may not affect 
the primary outcome substantially, they certainly could 
be reflected in the complication rate and the need to 
convert to open surgery. A combination of these factors 
may even render the procedure unfeasible in our setting. 
These factors can also have a significant impact on cost 
and further implementation of the procedure.
While patients undergoing LHM were significantly 
younger than those with OHM, the mean age for both 
cohorts is dramatically younger than in previously 
published data on western populations (12). This 
younger age reflects a possible difference in disease 
aetiology, population characteristics or risk factors and 
warrants further study.
With the advent of minimally invasive procedures, 
reduced complication rates and decreased hospital 
length of stay have been demonstrated among primarily 
western patient populations (7). In this study, we aimed to 
demonstrate that LHM does not have inferior outcomes 
to OHM, which has been carried out for longer in most 
parts of Africa and indeed in Kenya. Alleviating patient 
symptoms may be greater with LHM, which showed a 
trend toward shorter hospital length of stay.
It is not surprising that the duration of surgery was longer 
for the laparoscopic cases, which we can attribute to 
the challenges faced in a resource-limited environment 
coupled with the procedure’s steep learning curve.
The surgeons who performed the procedures had 
previous experience in a western setting, and a true 
learning curve that accompanies a de novo introduction 
of LHM would not be reflected in this study. Laparoscopy 
was introduced at the facility in 2009 and its use gradually 
increased to become the main treatment modality for 
achalasia.
Previously published work notes that this learning curve 
typically plateaus after 20 esophagomyotomies, at which 
point the surgeon has accumulated sufficient experience 
and confidence (13). Anecdotally, technical issues that 
may have contributed to duration of the procedure 
included frequent malfunction of the equipment 
with difficulty in troubleshooting, thus prolonging 
operative time. Our conversion rate of 10.71% and low 
complication rate agree with other literature, indicating 
the feasibility of LHM in our setting (1,14).
The limitations of this study include its retrospective 
nature, particularly in defining preoperative Eckardt 
scores from data in patient charts. In addition, variability 
in the level of proficiency of operating surgeons 
was not evaluated in this study. Within a teaching 
institution such as a rural hospital in Kenya, the case 
could be performed by an attending surgeon or by a 
surgical resident under the supervision of the attending 
surgeon; however, which individual performed critical 
portions of the case is not routinely recorded in the 
medical record. Patient follow-up was poor as most of 
the patients would not attend follow-up clinics in the 
recommended time post-procedure. Some did not 
provide a telephone contact which in turn had the effect 
of prolonging the time to complete the questionnaire. 
An additional limitation is the lack of documentation 
on the choice of laparoscopy versus an open procedure. 
The initial thought was that this decision was based on 
the availability of laparoscopy services during the study 
period (i.e. availability of working equipment and CO2). 
However, a notable difference in baseline characteristics 
was that older patients were more likely to undergo an 
open procedure, owing to patient or surgeon preference, 
but this warrants further investigation. Our analyses 
were limited by our small sample size, so while the study 
provides an initial snapshot of LHM within an East 
African population, further studies with larger samples 
sizes would be beneficial. A prospective arm of study 
is being considered to evaluate the changes, if any, that 
have been brought about by introducing laparoscopy in 
our setting.
Conclusion
We demonstrate that laparoscopic Heller esophagomyo-
tomy is effective and safe in a rural East African setting, 
with excellent functional outcomes compared with open 
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techniques, despite several limitations ranging from 
limited availability of advanced diagnostic modalities 
(manometry), advanced patho-logy at presentation and 
lack of funds (patient) to sub-optimal patient follow-
up. Our findings contribute to growing evidence that 
laparoscopy can be feasible worldwide.
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